Tova Waks
Rehovot, M 76100, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Anti-viral CD8 central memory veto cells as a new platform for CAR T cell therapy.
Journal: Stem cells translational medicine
Published: October 08, 2024
Nanoscale CAR Organization at the Immune Synapse Correlates with CAR-T Effector Functions.
Journal: Cells
Published: August 01, 2023
Extracellular Vesicles Derived from Chimeric Antigen Receptor-T Cells: A Potential Therapy for Cancer.
Journal: Human gene therapy
Published: September 08, 2021
P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas.
Journal: Nature communications
Published: February 16, 2020
Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity.
Journal: Cancer immunology research
Published: February 06, 2020
Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach.
Journal: Cancer immunology, immunotherapy : CII
Published: June 11, 2019
Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: August 25, 2017
The emergence of T-bodies/CAR T cells.
Journal: Cancer journal (Sudbury, Mass.)
Published: March 27, 2014
Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 10, 2013
Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 23, 2013
Last Updated: 09/26/2026